ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SBTX Skinbiotherapeutics Plc

9.25
0.00 (0.00%)
03 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherapeutics Plc LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 9.25 9.00 9.50 9.25 9.25 9.25 59,297 08:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 132k -2.84M -0.0163 -5.67 16.1M
Skinbiotherapeutics Plc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker SBTX. The last closing price for Skinbiotherapeutics was 9.25p. Over the last year, Skinbiotherapeutics shares have traded in a share price range of 7.25p to 29.50p.

Skinbiotherapeutics currently has 174,004,323 shares in issue. The market capitalisation of Skinbiotherapeutics is £16.10 million. Skinbiotherapeutics has a price to earnings ratio (PE ratio) of -5.67.

Skinbiotherapeutics Share Discussion Threads

Showing 1376 to 1397 of 23600 messages
Chat Pages: Latest  56  55  54  53  52  51  50  49  48  47  46  45  Older
DateSubjectAuthorDiscuss
03/3/2018
23:05
How discouraging and disappointing is it to revisit this site only to find Bob is still shoring it up!!!!
owenmo
02/3/2018
11:49
HERE IS AN INTERESTING ARTICLE that may eventually show SkinBio's creams prevent skin cancer.

Common human skin bacteria could protect against cancer, say researchers
Staphylococcus epidermidis may help to protect against skin cancer, and could lead to preventive treatments, scientists reveal

bobalot
02/3/2018
11:13
We know the human trials are scheduled for Q3 but what do people see as the drivers of the share price before that? I realise when things are being announced in anticipation of the Q3 trials we should see the share price rise.
rafboy
02/3/2018
07:53
Parob

It's a level book for the first time since float so driven by buys and sells.

Doesn't take much to move this now as we've seen this week.

A few buys at bell and it will go again.

Has the feel of n4p

shrewdmole
01/3/2018
18:53
Decent volume today. Hasn't looked this good for months! This should build nicely leading up to the trials.
parob
01/3/2018
14:34
A guy last week was primed to buy in heavily in the event of 2.5p. price shift (South). Well as of now we've got our 2.5p. only the wrong way for our would-be buyer. And so as and when this thing hits £1. buying to-day, he'd hold 50% less than last week's wished-for purchase; then of course half-a-loaf and all of that! Should have bought at 7.5 is the point I made at the time.
owenmo
01/3/2018
14:26
New Interview on Directors Talk today:

INTERVIEW: SkinBioTherapeutics Plc Positive Progress since October

Posted by: giles.arbor 1st March 2018

SkinBioTherapeutics Plc (LON:SBTX) CEO Dr. Cath O’Neill talks to DirectorsTalk about the progress made since FY results in October 17. Cath provides us with an update, reminds us what SkinBioTherapeutics does and how its SkinBiotix® technology works, areas of skin health focused on, the significance of the successful scale-up and formulation, next milestones, other programmes and getting to market and progress on possible commercial partners.

parob
01/3/2018
14:25
Looking good, breaking out of the down trend.
matt123d
01/3/2018
14:19
Shrewdmole, very happy for you to be correct. Nice rise today.
rafboy
01/3/2018
14:17
Who would have thought my skinbio shares would be my safe harbour today :)
rathean
01/3/2018
13:57
It is worth noting that the three products can be offered either as a cream, gel or lotion which means the product can have more applications and is therefore more versatile and that equates to a wider audience of end users and higher revenues.
bobalot
01/3/2018
11:35
Raf

Tbh and it's far from a ramp I think if the human trials are successful ta worth way more than £30m ish.

I jus think we could get a surprise whereby a company like johnson and johnson license a product and take it through the funding for the trials.

Time will tell but it's very clever how soh has got partners to fund 500k plus on certain deals and further r and d....

shrewdmole
01/3/2018
11:26
Shrewdmole, I think you could be quite correct. Now is probably a great time to add before the human trials in Q3. Once these are announced the price will rise in anticipation. I am working on a conservative 30p by year end.
rafboy
01/3/2018
10:04
My reasoning behind adding here is 2 fold.

First we seem to have an orderly book for the first time since the listing.

And secondly I believe that the in specie divi of Sbtx shares by Opti will be accompanied by a major step change Rns for Sbtx. Eg successful human trials and or commercial agreement.

The fact they've scaled up test production and identified dosage and re application intervals says to me they are about there.

Knowing how Opti have managed to get partners to fund further trials and r and d the human trial may have gone back slightly as it will come AFTER a commercial agreement and therefor get the partner I pay for those trials?!?!

Just my thoughts on a snowy day!

shrewdmole
01/3/2018
08:28
Well I've put my money where my mouth is so added 85k.
shrewdmole
28/2/2018
13:28
Agreed Shrewdmole.
elrico
28/2/2018
13:12
Personally I think this has been derisked more than people think and if you do the dd the info is out there.

Sub 10p is a bargain IMHO.

S

shrewdmole
28/2/2018
11:04
ODR - prob good average point, accumulation mode, if you will on weakness. Some PI's don't have the nerve for it, instead preference is to buy into a rising SP, which I find odd because this obviously reduces the gains - least that is my logic.
elrico
28/2/2018
09:41
Took advantage with another 41k.
onedayrodders
28/2/2018
09:28
Look how quickly they run the share price down on far less volume.
Don't you just love AIM.

onedayrodders
27/2/2018
16:18
An excellent interview with Dr. Cath who says some very interesting things about probiotics in the skin care industry.


SkinBioTherapeutics 'making very good headway' in development of three key programmes

16:02 26 Feb 2018

bobalot
27/2/2018
14:49
https://www.directorstalk.net/probiotics-skin-next-big-thing-beauty/
elrico
Chat Pages: Latest  56  55  54  53  52  51  50  49  48  47  46  45  Older

Your Recent History

Delayed Upgrade Clock